_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg)
CAR-T cell therapy shows promising early results for stiff person syndrome
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for stiff person syndrome (SPS), a rare autoimmune neurologic disorder, has produced promising early results.
Read original article on The Medical News →Related news
-
Computer models suggest ways to reduce side effects of chemotherapy in children
United Kingdom
-
Two newly identified protein forms may play a role in Alzheimer's
United Kingdom
-
COVID-19 tracing apps had limited impact as governments failed to integrate them, review finds
United Kingdom
-
Joint statement outlines faster endovascular bleeding control in trauma care
United Kingdom
-
Common risks for falling that most Americans overlook
United Kingdom
-
Is it a sinus infection, allergies or both?
United Kingdom
-
How a protein contributes to blood vessel damage in the brain in patients with malaria
United Kingdom
-
This Diwali, Trade the Doom Scroll for these 10 Questions
United Kingdom